XML 32 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue recognition
 3 Months Ended
Apr. 01, 2023
Revenue from Contract with Customer [Abstract]  
Revenue recognition Revenue recognition
Our policies for recognizing sales have not changed from those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The Company attributes net sales to external customers to the U.S. and to all foreign countries based on the legal entity from which the sale originated. The following table presents the Company’s net sales disaggregated by major products (Vertical) within each segment as follows:
Three Months Ended
April 1, 2023April 2, 2022
U.S.
Pain Treatments
$40,995 $47,874 
Restorative Therapies32,488 28,946 
Surgical Solutions30,495 27,261 
Total U.S. net sales103,978 104,081 
International
Pain Treatments
5,331 4,179 
Restorative Therapies5,614 5,414 
Surgical Solutions4,136 3,616 
Total International net sales15,081 13,209 
Total net sales$119,059 $117,290